CHICAGO, IL / ACCESSWIRE / August 23, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that the Company has regained compliance with Listing Rule 5250(c)(1) (the "Filing Rule"), in connection with the filing of its 2023 Annual Report on Form 10-K (the "Annual Report") and its financial results for the first quarter ended March 31, 2024, on Form 10-Q (the "First Quarter Report").
On April 17 and May 21, 2024, the Company received notification letters (the "Notification Letters") from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq") stating that it no longer met the periodic filing requirement for The Nasdaq Stock Market Filing Rule.
Based on the August 5 and August 19, 2024, filings of the Company's Form 10-K for the year ended December 31, 2023, and Form 10-Q for the period ended March 31, 2024, Nasdaq has determined that the Company complies with the Filing Rule. Accordingly, this matter is now closed.
Greg Siokas, CEO of Cosmos Health, stated: "We are extremely pleased to have regained compliance with Nasdaq, both in terms of filing our Annual Report and First Quarter Report, and meeting Nasdaq's Minimum Bid Price Rule earlier in July. As a result, Cosmos is now fully compliant with all Nasdaq listing requirements."
About Cosmos Health Inc.
Cosmos Health Inc. (Nasdaq:COSM), incorporated in 2009 in Nevada, is a diversified, vertically integrated global healthcare group. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe and C-Sept. Through its subsidiary Cana Laboratories S.A., licensed under European Good Manufacturing Practices (GMP) and certified by the European Medicines Agency (EMA), it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. Cosmos Health also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and OTC medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the UK. Furthermore, the Company has established R&D partnerships targeting major health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of novel patented nutraceuticals, specialized root extracts, proprietary complex generics, and innovative OTC products. Cosmos Health has also entered the telehealth space through the acquisition of ZipDoctor, Inc., based in Texas, USA. With a global distribution platform, the Company is currently expanding throughout Europe, Asia, and North America, and has offices and distribution centers in Thessaloniki and Athens, Greece, and in Harlow, UK. More information is available at , , , , as well as LinkedIn and X.
SOURCE: Cosmos Health Inc.
Cosmos Health Inc.（以下简称公司）（NASDAQ：COSM）是一家全球综合医疗集团，从事创新的研发、拥有专有的药品和保健品品牌、医疗产品制造和分销以及运营一家远程医疗平台。该公司宣布今日，公司已符合上市规则5250(c)(1)（以下简称“申报规则”），与提交其2023年年报表格10-K（以下简称“年报”）和2024年3月31日止的第一季度财务报告表格10-Q（以下简称“第一季度报告”）有关。
2024年4月17日和5月21日，公司收到了纳斯达克股票市场（以下简称纳斯达克）上市资格部门发出的通知函（以下简称“通知函”），说明公司不再符合纳斯达克股票市场的定期申报要求。
根据公司于2024年8月5日和8月19日提交的2023年报表10-K和截至2024年3月31日的第一季度报告表10-Q，纳斯达克已经确认公司符合申报规则。因此，此事现已结案。
Cosmos Health的首席执行官Greg Siokas表示：“我们非常高兴已经重新符合纳斯达克的规定，无论是提交我们的年度报告和第一季度报告，还是在7月份早些时候符合纳斯达克的最低标价规则。因此，Cosmos现在完全符合所有纳斯达克上市要求。”
Cosmos Health Inc.（纳斯达克:COSM）成立于2009年，总部位于内华达州，是一家全球健康医疗集团公司。公司拥有一系列专有药品和保健品牌，包括Sky Premium Life，Mediterranation，bio-bebe和C-Sept。公司的子公司Cana Laboratories S.A.获得欧洲GMP许可和欧洲药品管理局认证，生产医药品、食品补充剂、化妆品、生物灭菌剂和医疗设备等产品，并经营欧盟内的销售。此外，Cosmos Health还通过希腊和英国的子公司向零售药店和批发经销商销售广泛的药品和非处方药品，包括品牌仿制药和OTC药品。此外，该公司还与人工智能药物再利用技术合作，专注于研发针对肥胖症、糖尿病和癌症等主要健康障碍的研发合作，并专注于研发新的专利营养保健品、特殊植物提取物、专有复合仿制药和创新非处方药品。Cosmos Health还通过收购总部位于德克萨斯州的ZipDoctor，Inc进入了远程医疗领域。公司正在全球范围内扩张，并在希腊的塞萨洛尼基和雅典、英国的哈洛等地设有办事处和配送中心。 更多信息请访问公司网站：，以及LinkedIn和X。
资讯来源：Cosmos Health Inc.
